Introduction
With increasing public and media interest in sexual and erectile function disorders, patients' awareness of penile deformity and angulation with concomitant sexual dysfunction, that is, Peyronie's disease (PD) is emerging as well. As for erectile dysfunction, patients with PD are seeking professional help more frequently than just a decade ago. Although recognized as a disease entity almost half a millennium ago by Fallopius (1561) and described by Francois Gigot de la Peyronie in 1743, efficacious conservative management is still missing. 1, 2 In the late 1980s, the concept of shockwave therapy was added to the armamentarium of conservative topic or semi invasive treatment for PD. 3 Shockwave therapy has found widespread use in orthopedic disorders. Analgesic and functional results are competitive, especially in epicondylopathies (ie golfers and tennis elbow), painful heel and tendinosis calcarea of the shoulder. 4 The observation of encouraging results in orthopedic disorders that share certain morphologic features with PD (calcification, disorder of connective tissue, pain) lead urologists to ESWT for PD. In the past 5 y several studies were published evaluating the efficacy of ESWT in the treatment of PD. [5] [6] [7] [8] [9] [10] [11] [12] Uniformly, almost all of them considered ESWT a safe and efficient treatment for complications of PD. Not only effective pain reduction was reported but also significant correction of penile deformity was observed. Results concerning long-term follow-up though are missing.
Patients and methods
From September 1999 to January 2001, we evaluated 52 patients with PD who were enrolled prospectively in our study. 
Results
In all, 52 patients were prospectively included with a mean age of 55.6 y (range 29-77 y). Mean duration of disease was 19.3 months (range 4-168 months) and median duration was 12 months, respectively. Before ESWT intercourse was difficult or impossible for 40 men, 29 patients suffered mainly from penile deformity, 14 from painful erection and nine mainly from loss of distal rigidity ( Table 2 ). All 52 patients were evaluated 6 weeks after ESWT for early followup. A total of 22 patients had an unsuccessful medical therapy for PD. Of these 11 patients had a course of vitamin E treatment for 4.6 months on average, potassium aminobenzoate was used by 10 patients and one patient had experienced a medical therapy with chondroitinsulfate.
In total, 30 patients mentioned painful erections before treatment. The pain score was higher in patients with a longer duration of disease who had a score of 2.8 compared to patients below 12 months duration of disease with a score of 2.1 (Po0.12). In 28 out of 30 patients (93%) pain reduction was achieved, total relief of pain in 19/30 (63%). The mean pain score dropped from 4.2 to 1.3 in the 14 patients who suffered predominantly from painful erections (Po0.01). In the whole group of patients suffering from painful erections the mean pain score dropped from 3.9 to 0.6, which was significant. Patients with a longer duration of disease had a relatively higher decrease of pain compared to those patients with a shorter duration of disease. However, in the end both groups showed a score of 0.6 after treatment. This difference did not reach a level of statistical significance.
Sexual intercourse satisfaction improved in 11 out of 40 patients after therapy. The mean age in patients noticing an improvement in intercourse competence 
Duration of disease had no significant impact on reduction of penile angulation. The degree of penile angulation had no statistical impact on treatment success. The first third of patients with a mean angulation of 171 before treatment had an angulation of 151 after therapy, the second third had 411 before and 431 after ESWT and the last third of patients with a mean deviation of 611 had an improvement of penile angulation of 101, which did just not reach a level of statistical significance. Plaque size before ESWT was 246 and 242 mm 2 thereafter. Calcification of plaques assessed by ultrasound was present in 57% of patients before and 53% of patients after ESWT. The presence of calcification had no significant impact on treatment success. No change of loss of distal rigidity was observed.
Complication rate was low with only minor side effects. Essentially, minimal skin bruising was observed in 103 out of 260 treatment sessions. In the vast majority they were resolved before the next session followed 1 week later. One patient tolerated the shockwave therapy only with local anesthesia. All others in fact were treated without any anesthesia or analgesics. One urethral bleeding occurred that resolved spontaneously within 24 h without sequel in late follow-up after 12 months.
Late follow-up after a mean of 11.1 months (4-17) could be completed in 36 patients. Unfortunately, only five out of 16 patients who did not return the questionnaire could be contacted by phone. All others were lost to follow-up. They did not respond to the questionnaire for different reasons and were not included in the analysis. Restricted intercourse persisted in 23 men and intercourse was impossible for six patients, and thus penetration/intercourse dissatisfaction was even now the main symptom. Penile deformity bothered 25 patients, eight patients suffered mainly from painful erections and three patients quoted nothing. In all, 19 men reported that ESWT improved their PD. Of these, 16 noted no change. Only one of the patients noticed a worsening of his disease during or after treatment. The mean penile curvature did not change significantly in the group eligible for late follow-up (391 before treatment and 431 11 months after treatment). A total of 24 patients would consider ESWT again to treat their disease, 12 patients would not perform shockwave therapy again to treat PD. The mean pain score remained on a low level and was 1.0 on the visual analogue scale.
Discussion
In theory it might appear plausible to break up plaques of the tunica albuginea with shockwaves. Thus far sound experimental evidence and explanation of the shockwave's impact and effect on fibrous or even calcified plaque of the tunica albuginea of the corpus cavernosum is still missing. In addition, with regard to pathogenetic theories concerning PD ESWT might be counterproductive. Even more so, it might induce micro injuries of the tunica albuginea and thus propagate the disease. 13, 14 After our preliminary series with a Dornier Epos Ultra Device (Dornier, Wessling, Germany) reporting only on 15 patients, we evaluated ESWT with a Siemens Multiline Lithotripter. 15 Unexpectedly, our results do differ considerably concerning correction of penile curvature with ESWT despite using similar treatment setups and devices as in other recently published studies. [5] [6] [7] [8] [9] [10] [11] Besides, patient characteristics before treatment including penile angulation, plaques size and pain during erection, and age are probably comparable to parameters of other reports. 6, 7 It is not mere penile deformity that bothers patients and their partners, but difficulties in penetration which is annoying. As our study demonstrates, penile angulation of more than 40-501 interferes with penetration competence and intercourse satisfaction. In other published studies improvement in penile deformity is quoted. However, not every penile angulation leads to penetration difficulties and thus improvement in angulation does not necessarily equal higher intercourse satisfaction. Likewise, pain reduction did not lead to higher intercourse satisfaction. In the small subgroup of patients with improvement of intercourse competence, a more pronounced reduction of penile deformity was achieved. In contrast to a previously published study, these patients showed also a shorter duration of disease than the entire group. 8 Patient characteristics and the number of patients treated are too small and inconsistent to determine predictors of treatment success. Although patients with a higher degree of angulation before treatment showed a more pronounced reduction of penile angulation on average after therapy than patients with lower degrees of angulation, this did not reach statistical significance. Furthermore a reduction of 61-511 might not have led to improved intercourse satisfaction as patients with penile angulation more than 40-501 suffered from impaired intercourse satisfaction anyway.
Extracorporeal shockwave therapy for Peyronie's disease RT Strebel et al ESWT did reduce pain on erection in our study in patients suffering from painful erection due to PD. Interestingly patients with disease duration longer than 12 months (median) had, although statistically not reaching a level of significance, initially a higher pain score than patients with a shorter disease duration, which is somehow in contrast with the natural history of disease with its spontaneous resolution of pain at times. 16 As expected, there was no change in loss of distal rigidity during erection. Furthermore, plaque size, which covered an area of 246 mm 2 , remained unchanged after treatment and thus is in accordance with other reports. 6, 7 In total contrast to our results, some authors reported a reduction in plaque size in other previously published studies. 5, [17] [18] [19] The assessment at 'late follow-up' was performed with a self-reporting questionnaire without any additional clinical examination. Thus, the long-term data of this study are not determined objectively. However, patient's self-assessment is considered a valuable method and has no false positive bias, which is often observed with the so-called objective measurement and evaluation by physicians. 20 Admittedly, we did not use a validated questionnaire to assess intercourse satisfaction, and thus these results must be interpreted with caution. Even though criticized in other reports, we assessed penile angulation on photographs taken by the patients in a home setting before ESWT and 6 weeks after treatment. Noteworthy penile angulation showed only minimal difference between goniometric measurements on photographs 6 weeks after ESWT and determination by the patients collected with the questionnaire 11 months after ESWT. Pain during erection remained on a low level, which again might be either due to the natural history of the disease or possibly to ESWT. Nevertheless, intercourse difficulties persisted on a high level. As seen in other studies side effects were minimal. In addition, looking at the results of the late followup admittedly after a period of only 11 months, it seems that ESWT had no negative impact on the disease, as penile angulation remained statistically unchanged.
Conclusions
In our experience ESWT for PD is not a very effective treatment for the main complications of the disease. Penile angulation, plaque size and thus most importantly, intercourse satisfaction showed only little improvement in our patients. In addition, data of the literature are controversial, and no reports of long-term follow-ups are published. Therefore, we do not recommend ESWT as a primary treatment for penile deformity and intercourse difficulties due to PD.
